This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
SAN DIEGO, Sept.10, 2013 /PRNewswire/ --
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced the completion of an initiative to standardize chemical structure perception across the
Accelrys Enterprise Platform and the
Accelrys Direct data cartridge for Oracle. Harmonized cheminformatics technology from Accelrys enables scientists to represent molecules, reactions, biologics and conjugates consistently across applications developed using the Accelrys Enterprise Platform and Accelrys Direct.
New releases of
Accelrys Chemical Registration and
Accelrys Biological Registration leverage the capabilities of Accelrys Direct to provide consistent registration of small molecules, biologics, chemically modified biologics and conjugates. The Accelrys registration applications enable organizations to capture and secure intellectual property (IP) pertaining to molecules and biologics in an environment that improves efficiency, protects IP, lowers costs associated with the unnecessary production of duplicate entities and improves traceability for regulatory agencies.
"With pharma and biotech companies moving to portfolios spanning small molecules, biologics and antibodies, medicinal chemists and molecular biologists must register and track an extensive set of entities," said
Matt Hahn, Ph.D., senior vice president and chief technology officer, Accelrys. "The Accelrys Cheminformatics Suite, anchored by Accelrys Direct and our chemical and biological registration applications, meets customers' fundamental needs for end-to-end combined chemical and biologics acquisition, registration and management in today's increasingly integrated chemical and biological R&D environment."
The Accelrys Direct data cartridge ensures the fidelity of chemical information across Accelrys solutions and enables multidisciplinary project teams to explore novel chemical structures and macromolecular sequences stored in a single corporate registry. Accelrys Direct offers proven performance with databases containing more than 69 million structures and more than 17 million reactions. Accelrys Direct 9.0 provides harmonized chemistry representation, perception and search with Accelrys Enterprise Platform 9.0 along with other new features and enhancements. The Accelrys Enterprise Platform is the foundation for Accelrys' scientific software and services, enabling organizations to access and gain value from complex data across the enterprise and to integrate and deploy broad scientific solutions from research and development through quality control and manufacturing.